Daré Bioscience, Inc. (DARE)
0.7428
0.00 (0.00%)
USD |
NASDAQ |
Sep 03, 13:03
Daré Bioscience Cash from Investing (Quarterly) : -0.0806M for June 30, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.0806M |
| March 31, 2026 | 0.00 |
| December 31, 2025 | -0.2066M |
| September 30, 2025 | -0.1747M |
| June 30, 2025 | 0.1534M |
| March 31, 2025 | -0.1573M |
| September 30, 2024 | 0.2823M |
| June 30, 2024 | -0.2852M |
| March 31, 2024 | -0.0073M |
| December 31, 2023 | -0.6073M |
| September 30, 2023 | -0.0221M |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | -0.0027M |
| September 30, 2022 | -0.055M |
| June 30, 2022 | -0.0008M |
| March 31, 2022 | -0.0046M |
| December 31, 2021 | 0.00 |
| September 30, 2021 | -0.0145M |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | -0.0024M |
| September 30, 2020 | 0.00 |
| June 30, 2020 | -0.0152M |
| March 31, 2020 | 0.00 |
| Date | Value |
|---|---|
| December 31, 2019 | 6.144M |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | -0.0586M |
| June 30, 2018 | -0.4602M |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 9.918M |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | -0.036M |
| September 30, 2016 | -0.027M |
| June 30, 2016 | -0.113M |
| March 31, 2016 | -0.242M |
| December 31, 2015 | -0.113M |
| September 30, 2015 | -0.034M |
| June 30, 2015 | -0.308M |
| March 31, 2015 | -0.029M |
| December 31, 2014 | -0.109M |
| September 30, 2014 | -0.078M |
| June 30, 2014 | 0.006M |
| March 31, 2014 | -0.004M |
| December 31, 2013 | 0.00 |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Nektar Therapeutics | -399.11M |
| Elite Pharmaceuticals, Inc. | -0.809M |
| Eton Pharmaceuticals, Inc. | 0.005M |
| ANI Pharmaceuticals, Inc. | -3.054M |
| Corcept Therapeutics, Inc. | -29.24M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -6.775M |
| Cash from Financing (Quarterly) | 0.9512M |
| Free Cash Flow | -11.76M |
| Free Cash Flow Per Share (Quarterly) | -0.4604 |
| Free Cash Flow to Equity (Quarterly) | -6.436M |
| Free Cash Flow to Firm (Quarterly) | -6.665M |
| Free Cash Flow Yield | -111.7% |